Ratings Aviva plc Euronext Paris

Equities

AV

GB0002162385

End-of-day quote Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

May. 16	Bens Creek considers administration; Nexxen inks deal	AN
May. 14	Britain rejects call to ban gagging orders in finance	RE

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

With a P/E ratio at 11.73 for the current year and 10.3 for next year, earnings multiples are highly attractive compared with competitors.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
This company will be of major interest to investors in search of a high dividend stock.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company does not generate enough profits, which is an alarming weak point.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AVIVA PLC	-.--%	16.81B	-
AXA	+14.45%	80.59B	B-
METLIFE, INC.	+10.22%	52.78B	B+
AFLAC INCORPORATED	+6.29%	50.21B	B
MANULIFE FINANCIAL CORPORATION	+24.11%	47.96B	B+
GENERALI	+24.78%	41.99B	B
SUN LIFE FINANCIAL INC.	+2.40%	30.06B	B
GREAT-WEST LIFECO INC.	-2.49%	29.32B	B-
PRUDENTIAL PLC	-9.24%	28.52B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+22.40%	25.69B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes